Timely clinical updates and thought leadership on new drug and indication approvals, discontinuation and withdrawals, new dosages or formulations of existing products and generics introduced to the market. For questions regarding new updates, please email clinical@myMatrixx.com.
News and Updates
ODG Formulary Changes Planned for March 29
FDA Approves Wegovy for Prevention of Major Cardiovascular Disease in Obese or Overweight Adults